McKesson’s Latest Updates on COVID-19 (coronavirus)

As one of the world’s largest healthcare companies, we know we have a critical role to play in making medications and supplies available to customers and patients when they need them.

We recognize our role is even more important at this moment. It is something we take seriously every day and even more so right now as the world faces this healthcare challenge.

We are taking all the necessary steps to make sure that we do everything that we can to continue to supply our customers and protect the safety of our employees. We’re working tirelessly to address new developments as they occur. We are in close contact with regulatory authorities around the world to ensure we are well-prepared to address our customers’ evolving needs so that they can best care for their patients.

We will continue to provide updates here as they become available.

March 30, 2020:

Yesterday, our CEO Brian Tyler had the opportunity to underscore to President Trump, Vice President Pence and other administration officials the critical role McKesson plays in the medical supply chain and outline all the ways in which we are doing our part in the fight against the COVID-19 pandemic.

As a distributor of essential health care supplies and medicines, we are working closely with the administration, the Federal Emergency Management Agency, the Department of Health and Human Services, as well as other federal and state agencies and industry partners to ensure supplies and medicine reach those who need them most – people on the front lines of this pandemic.

March 20, 2020:

Personal Protective Equipment (PPE)

Unfortunately, customers may not be able to get enough PPE from McKesson to satisfy their needs. The demand for PPE continues to increase daily in the U.S., compounding the unprecedented global surge in demand for these items that started in late January. In addition to the increase in need, production delays from manufacturers in China continue to impact both current inventory and how quickly resupply can become available in our distribution centers.

In order to support as many providers and patients as possible, for as long as possible, and to prevent hoarding, we’ve put some restrictions in place for PPE items. These restrictions include limiting orders to only current customers and monitoring the amount they’re ordering.

We’ll continue to monitor the situation and proactively address issues as needed. We’re committed to getting critical supplies to customers who need them and are working with industry partners and government agencies such as the CDC, HHS, and FEMA to anticipate product needs.

Supplies of Medications

We are actively working with manufacturers, industry partners and government agencies to anticipate shortages and respond to unprecedented demand for certain medications. The situation remains fluid, and we are taking a proactive approach to protect inventory and make sure our provider partners have the supplies and medications they need to treat patients and help stop the spread of COVID-19. With that, we are allocating key product categories to ensure equitable distribution.

Allocated product categories:

  • Antibiotics
  • Statins
  • Antivirals
  • Nebulizer solutions and respiratory medications

Although we are allocating products, all current allocations have been set at more than 100% of historical product usage. McKesson will make every effort to provide our customers with a minimum of 100% of their historical usage as long as the product is available. For orders that exceed historical usage, we have a process in place to accommodate reasonable and needed customer requests. For assistance please work with your account representative.

March 12, 2020:

On March 11, 2020, the World Health Organization (WHO) officially declared the COVID-19 virus a pandemic as the number of people who have been diagnosed continues to increase. As a company that is unique in our ability to help address this global health crisis, we are focused on doing everything we can to support our customers so that they can treat patients who need care.

It’s important that we immediately take broad, proactive measures to protect the health of our employees as we continue to support our customers who are working tirelessly to meet patients’ needs, so effective March 12, we are implementing several new measures across all McKesson U.S., Canada and International operations.

  • Travel: We are restricting all domestic and international business travel.
  • Meetings: Although we’re disappointed that we won’t be able to meet with our customers and partners in person, we are cancelling or rescheduling all large group in-person meetings, and restricting visitors to only those required for essential business meetings.
  • Telecommuting/Work from Home: We are instituting, and strongly encouraging, voluntary telecommuting/work from home for all McKesson employees who do not have to be onsite to perform their roles.

As we continue to navigate through this challenging period, we want to specifically recognize the tremendous efforts of our critical employees such as those in our distribution centers and call centers who will continue coming to work to maintain services essential to the delivery of healthcare. The steps we are taking today are designed to protect them as well by minimizing their exposure to large groups at work.

McKesson is a special place. In challenging times, we rally around our customers, one another and, in this situation, the role that we can play in helping our communities, our countries and the world. It’s what we do because it’s who we are. As one of the largest healthcare companies, we have an obligation to take these actions – and potentially others – to help mitigate the spread of this virus and the potential impact on the healthcare system.

March 6, 2020:

Does McKesson have enough Personal Protective Equipment (PPE) to satisfy customer orders?

Since late January, there has been an increase in demand for personal protective equipment (PPE) due to COVID-19 as well as a persistent U.S. flu season. In order to support as many providers and patients as possible, and prevent hoarding, we have put some restrictions in place for PPE items such as limiting orders for existing customers so that they stay in line with prior order quantities. We will continue to monitor the situation and proactively address issues as needed.

We’re committed to getting critical supplies to customers who need them and are working with industry partners and the CDC to anticipate product needs.

How is COVID-19 affecting other business units of McKesson?

We’re committed to providing medications and supplies to customers who need them, and are working with manufacturers, industry partners and government agencies to anticipate demand. McKesson Medical-Surgical is closely monitoring the supplies of PPE and working to address supply constraints. We are also working with our manufacturer partners outside of China to increase their production and to identify other sources for PPE.

How is McKesson safeguarding distribution operations?

We’re actively monitoring regions where COVID-19 has spread and have continuity plans in place to help protect our employees, which in turn will preserve our ability to continue serving our customers. If a McKesson distribution center must close, including one that provides specialty medications, we currently have the ability to fill orders at one of our other distribution centers.

Please contact your McKesson account manager with any specific inquiries.